antibiotic resistance

UroPharma is moving rapidly to commercialisation. The science and momentum are with us.

We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....

New opportunities in bladder treatments.

As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

New Bladder therapies to ease the suffering of millions by simply changing clinical practice.

UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

Benefits of Direct-to-Bladder drug targeting.

Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...